Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa

BACKGROUND: Colistin has a narrow therapeutic window with nephrotoxicity being the major dose-limiting adverse effect. Currently, the optimal doses and therapeutic plasma levels are unknown. METHODS: Prospective observational cohort study, including patients infected by colistin-susceptible P. aerug...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Infect Dis
Autores principales: Sorlí, Luisa, Luque, Sonia, Segura, Concepción, Campillo, Nuria, Montero, Milagro, Esteve, Erika, Herrera, Sabina, Benito, Natividad, Alvarez-Lerma, Francisco, Grau, Santiago, Horcajada, Juan Pablo
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217330/
https://ncbi.nlm.nih.gov/pubmed/28056821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-2117-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares